department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Janssen-Cilag Holdings Inc (Inactive) · pharmadog

PUBLIC COMPANY

Janssen-Cilag Holdings Inc (Inactive)

updated 1mo ago

community read0 votes

pipeline

3

marketed

3

phase 3

0

catalysts ytd

7

approvals ytd

7

recalls ytd

0

Pipeline(3)

pipeline depth3 products

3Marketed

EPOPROSTENOL SODIUM

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Janssen-Cilag Holdings Inc (Inactive) jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

mentioned in

0news items

entity-linker matched

Data sources

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Active trials

phase3A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Diseaseactive not recruitingn=288
—A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamideactive not recruitingn=504
phase3Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patientsactive not recruitingn=120
—A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasisrecruitingn=200
—A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participantsnot yet recruitingn=200
—A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trialsrecruitingn=900
—A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)recruitingn=220
—A Real-world Study in Participants With Smoldering Multiple Myelomacompletedn=431

more trials →

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?